Equity analyst research on UK stocks from DirectorsTalk

Five UK Stocks to Watch in 2024
[shareaholic app="share_buttons" id_name="post_below_content"]

DirectorsTalk brings you professional opinions from leading equity research analysts on companies listed on the London Stock Exchange. This article contains a small selection of five stocks in the clean energy, financial services and telecommunications sectors. Equity analyst research across all sectors is available here. DirectorsTalk aims to help investors make more informed investment decisions.

Quadrise plc (LON:QED) produce transition fuels called MSAR® (pronounced ‘em-sar’) and bioMSAR™, which allow clients in the shipping, utilities and industrial sectors to reduce carbon emissions whilst also saving costs.

Arbuthnot Banking Group PLC (LON:ARBB), trading as Arbuthnot Latham, provides private and commercial banking products and services in the United Kingdom.

TEAM plc (LON:TEAM) is building a wealth, asset management and complementary financial services group. 

Cerillion plc (LON:CER) is a leading provider of billing, charging and customer management systems with more than 20 years’ experience delivering its solutions across a broad range of industries including the telecommunications, finance, utilities and transportation sectors.

Tern PLC (LON:TERN) is an AIM-listed provider of venture capital to exciting IoT innovators seeking scale and market share.

Share on:
Find more news, interviews, share price & company profile here for:

Pharma teams gain early insight into message effectiveness

Talking Medicines gives pharma teams early insight into which messages resonate with healthcare professionals.

Surge in gold and silver points to rising investor caution

Gold and silver gains suggest investors are shifting to safer ground amid rising political and market risks.

Arbuthnot Commercial ABL funds strategic acquisition in the UK fit‑out sector

Arbuthnot Commercial ABL has funded the acquisition of a regional contractor, combining speed and flexibility in support of a sponsor-led growth strategy.

Cerillion appoints Greg Price as incoming Chief Financial Officer

Cerillion has confirmed that Andrew Dickson will stand down from the Board on 1 March 2026 to pursue new opportunities. Greg Price, an experienced technology-sector CFO, will succeed him and is expected to join the Company and the Board by 1 May 2026, following completion of regulatory checks.

Talking Medicines joins 2026 UK AI Index

Talking Medicines joins the UK AI Index 2026, confirming its growing role in data-driven healthcare strategy.

The Diverse Income Trust: Why Gervais Williams Is Doubling Down on Overlooked UK Small Caps (video)

Fund Manager Gervais Williams shares why the Diverse Income Trust is expanding positions in cash-rich, undervalued small caps — and highlights overlooked plays in energy, digital retail, and financials.

Search

Search